BioGENext-2024: shaping the future of medicine through biomedical R&D
The full-scale war and the COVID-19 pandemic proved once again that the preservation of people’s lives depends on the availability of innovative solutions.
Since 2015, the YURiA-PHARM Group has been developing a biotechnological R&D infrastructure YP Biotech, setting itself the goal of creating the first center in Ukraine, where a full cycle of biotechnological development for biomedical purposes will be carried out.
For almost 10 years of work in this field, we have experienced firsthand the importance of Partnerships, because biopharmaceutical development is a long and complex science-intensive process. We see how important it is to establish interaction between scientific groups, share experience, cooperate, create opportunities for the development and employment of highly qualified personnel (and their return to Ukraine!), as well as actively integrate with the international community.
We are convinced that an ecosystem is needed at the state level that will contribute to the development of the biopharmaceutical industry, because the process of transforming scientific ideas into therapeutic products requires:
- deep interdisciplinary expertise and cooperation;
- complex technological base;
- effective regulatory framework.
Contributing to the creation and development of such an ecosystem, in partnership with the Institute of Molecular Biology and Genetics of National Academy of Sciences of Ukraine, we initiated the holding of the first international scientific conference in Ukraine dedicated to the development of therapeutic solutions of the next generation BioGENext Conference.
Global biopharmaceutical developments today create the basis for the medicine of the future, and Ukraine should become a full participant in this process. We are convinced that the present, in addition to challenges, opens up great opportunities. Opportunities for the innovative future of Ukraine!
More information about BioGENext.
